Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

608 ARTÍCULOS , VIENDO DEL 241 AL 255

Prodromal Parkinson's Disease: The Decade Past, the Decade to Come

Postuma RB, Berg D.

Mov Disord. 2019 May;34(5):665-675. doi: 10.1002/mds.27670. Epub 2019 Mar 28.

Spiny Projection Neuron Dynamics in Toxin and Transgenic Models of Parkinson's Disease

Du Y, Graves SM.

Front Neural Circuits. 2019 Mar 15;13:17. doi: 10.3389/fncir.2019.00017. eCollection 2019.

Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients

Klietz M, Greten S, Wegner F, Höglinger GU.

Drugs Aging. 2019 Jun;36(6):511-530. doi: 10.1007/s40266-019-00654-z.

Influencing factors when living with Parkinson's disease: A cross-sectional study

Ambrosio L, Portillo MC, Rodriguez-Blazquez C, Rojo JM, Martinez-Martin P; EC-PC Validation Group.

J Clin Nurs. 2019 Sep;28(17-18):3168-3176. doi: 10.1111/jocn.14868. Epub 2019 May 13.

Characterizing advanced Parkinson's disease: OBSERVE-PD observational study results of 2615 patients

Fasano A, Fung VSC, Lopiano L, Elibol B, Smolentseva IG, Seppi K, Takáts A, Onuk K, Parra JC, Bergmann L, Sail K, Jalundhwala Y, Pirtosek Z.

BMC Neurol. 2019 Apr 2;19(1):50. doi: 10.1186/s12883-019-1276-8.

Animals in the Brain

Mulroy E, Balint B, Adams ME, Campion T, Merello M, Bhatia KP.

Mov Disord Clin Pract. 2019 Feb 28;6(3):189-198. doi: 10.1002/mdc3.12734. eCollection 2019 Mar.

Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging

Massa J, Chahine LM.

J Parkinsons Dis. 2019;9(2):327-334. doi: 10.3233/JPD-181517.

Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People With Parkinson Disease: A Randomized Clinical Trial

Kwok JYY, Kwan JCY, Auyeung M, Mok VCT, Lau CKY, Choi KC, Chan HYL.

JAMA Neurol. 2019 Jul 1;76(7):755-763. doi: 10.1001/jamaneurol.2019.0534.

Will genotype drive treatment options?

Brüggemann N, Klein C.

Mov Disord. 2019 Sep;34(9):1294-1299. doi: 10.1002/mds.27699. Epub 2019 Apr 10.

Targeting α-Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics

Savitt D, Jankovic J.

Drugs. 2019 Jun;79(8):797-810. doi: 10.1007/s40265-019-01104-1.

Extensive validation study of the Parkinson's Disease Composite Scale

Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group.

Eur J Neurol. 2019 Oct;26(10):1281-1288. doi: 10.1111/ene.13976. Epub 2019 May 31.

Efficacy of istradefylline for gait disorders with freezing of gait in Parkinson's disease: A single-arm, open-label, prospective, multicenter study

Iijima M, Orimo S, Terashi H, Suzuki M, Hayashi A, Shimura H, Mitoma H, Kitagawa K, Okuma Y.

Expert Opin Pharmacother. 2019 Aug;20(11):1405-1411. doi: 10.1080/14656566.2019.1614167. Epub 2019 May 28.

MDS evidence-based review of treatments for essential tremor

Ferreira JJ, Mestre TA, Lyons KE, Benito-León J, Tan EK, Abbruzzese G, Hallett M, Haubenberger D, Elble R, Deuschl G; MDS Task Force on Tremor and the MDS Evidence Based Medicine Committee.

Mov Disord. 2019 Jul;34(7):950-958. doi: 10.1002/mds.27700. Epub 2019 May 2.

Clinical and methodological challenges for assessing freezing of gait: Future perspectives

Mancini M, Bloem BR, Horak FB, Lewis SJG, Nieuwboer A, Nonnekes J.

Mov Disord. 2019 Jun;34(6):783-790. doi: 10.1002/mds.27709. Epub 2019 May 2.

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort

Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S.

J Neurol. 2019 Aug;266(8):1927-1936. doi: 10.1007/s00415-019-09348-3. Epub 2019 May 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias